Picture of Psyence logo

PSYG Psyence Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Psyence, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M10 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.019-0.093-11.3-4.6-6.08
Depreciation
Non-Cash Items0-0.039.170.9550.406
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-0.0130.076-0.1170.0331.94
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-0.032-0.046-2.2-3.56-3.64
Capital Expenditures-0.376-0.164-0.264
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.004-0.147-0.166
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-0.373-0.311-0.43
Financing Cash Flow Items0.03-0.034
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.038.671.272.96
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.032-0.0166.1-2.6-1.11